Olivia Kyusuk Bloom - Aug 15, 2023 Form 4 Insider Report for GERON CORP (GERN)

Role
EVP, Chief Financial Officer
Signature
/s/ Olivia K. Bloom
Stock symbol
GERN
Transactions as of
Aug 15, 2023
Transactions value $
$0
Form type
4
Date filed
9/21/2023, 09:31 PM
Previous filing
May 19, 2023
Next filing
May 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GERN Employee Stock Option (right to buy) Award $0 +250K $0.00 250K Aug 15, 2023 Common Stock 250K $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.